Heat shock proteins, autoimmunity, and cancer treatment

Autoimmune Diseases

Volumn 1, Issue 1, 2012, Pages

  Calderwood, Stuart K ^a   Stevenson, Mary Ann ^a   Murshid, Ayesha ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CHAPERONIN 60; GLYCOPROTEIN GP 96; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HSP70 MAGE 3 FUSION PROTEIN; PROTEIN GRP170; TUMOR ANTIGEN; UNCLASSIFIED DRUG; INTERLEUKIN 10;

ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CANCER STEM CELL; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEX FORMATION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TREATMENT RESPONSE; TUMOR GROWTH; CANCER THERAPY; CD4+ T LYMPHOCYTE; CELL VIABILITY; CROSS PRESENTATION; CYTOKINE RELEASE; EXOSOME; IMMUNOREGULATION; MICROENVIRONMENT; MYELOID DERIVED SUPPRESSOR CELL; PROGNOSIS; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN SECRETION; SUPPRESSOR CELL;

EID: 84874921468     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2012/486069     Document Type: Review

References (106)

1. Nikolich-Žugich J., Slifka M. K., Messaoudi I., The many important facets of T-cell repertoire diversity. Nature Reviews Immunology 2004 4 2 123 132 2-s2.0-1142274484 (Pubitemid 38209206)
2. Walker L. S. K., Abbas A. K., The enemy within: keeping self-reactive T cells at bay in the periphery. Nature Reviews Immunology 2002 2 1 11 19 2-s2.0-0036360019 (Pubitemid 37328771)
3. Pardoll D., Does the immune system see tumors as foreign or self? Annual Review of Immunology 2003 21 807 839 2-s2.0-0042470540 10.1146/annurev.immunol. 21.120601.141135 (Pubitemid 37174548)
4. Srivastava P. K., Old L. J., Individually distinc transplantation antigens of chemically induced mouse tumors. Immunology Today 1988 9 3 78 83 2-s2.0-0023818008 (Pubitemid 18053715)
5. Moller P., Hammerling G. J., The role of surface HLA-A,B,C molecules in tumour immunity. Cancer Surveys 1992 13 101 127 2-s2.0-0026749861
6. Chouaib S., Thiery J., Gati A., Guerra N., El Behi M., Dorothée G., Mami-Chouaib F., Bellet D., Caignard A., Tumor escape from killing: role of killer inhibitory receptors and acquisition of tumor resistance to cell death. Tissue Antigens 2002 60 4 273 281 2-s2.0-0036819226 10.1034/j.1399-0039.2002. 600401.x (Pubitemid 36020799)
7. Pekarek L. A., Starr B. A., Toledano A. Y., Schreiber H., Inhibition of tumor growth by elimination of granulocytes. Journal of Experimental Medicine 1995 181 1 435 440 2-s2.0-0028928899 10.1084/jem.181.1.435
8. Terabe M., Swann J., Ambrosino E., Sinha P., Takaku S., Hayakawa Y., Godfrey D. I., Ostrand-Rosenberg S., Smyth M. J., Berzofsky J. A., A nonclassical non-V α 14J α 18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. Journal of Experimental Medicine 2005 202 12 1627 1633 2-s2.0-29144484782 10.1084/jem.20051381 (Pubitemid 41815868)
9. Mantovani A., Allavena P., Sica A., Balkwill F., Cancer-related inflammation. Nature 2008 454 7203 436 444 2-s2.0-47949096781 10.1038/nature07205
10. Marigo I., Dolcetti L., Serafini P., Zanovello P., Bronte V., Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunological Reviews 2008 222 1 162 179 2-s2.0-41149119143 10.1111/j.1600-065X.2008.00602.x (Pubitemid 351430364)
11. + lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer. Breast Cancer Research 2012 14 2, article R48
12. Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pagès C., Tosolini M., Camus M., Berger A., Wind P., Zinzindohoué F., Bruneval P., Cugnenc P. H., Trajanoski Z., Fridman W. H., Pagès F., Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006 313 5795 1960 1964 2-s2.0-33749319703 10.1126/science.1129139 (Pubitemid 44498003)
13. Fridman W. H., Pages F., Sautes-Fridman C., Galon J., The immune contexture in human tumours: impact on clinical outcome. Nature Reviews Cancer 2011 12 298 306
14. + regulatory T cells in patients with colorectal carcinoma after IL-2 administration. PLoS ONE 2012 7 e30422
15. Schmidt A., Oberle N., Krammer P H., Molecular mechanisms of tregmediated T cell suppression. Frontiers in Immunology 2012 3 51 10.3389/fimmu.2012.00051
16. Visvader J. E., Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes and Development 2009 23 22 2563 2577 2-s2.0-72749103664 10.1101/gad.1849509
17. Schatton T., Frank M. H., Antitumor immunity and cancer stem cells. Annals of the New York Academy of Sciences 2009 1176 154 169 2-s2.0-70349552398 10.1111/j.1749-6632.2009.04568.x
18. Kraman M., Bambrough P. J., Arnold J. N., Roberts E. W., Magiera L., Jones J. O., Gopinathan A., Tuveson D. A., Fearon D. T., Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein- α Science 2010 330 6005 827 830 2-s2.0-78149298209 10.1126/science.1195300
19. Li G. C., Werb Z., Correlation between synthesis of heat shock proteins and development of thermotolerance in Chinese hamster fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 1982 79 10 3218 3222 2-s2.0-0020130877
20. Calderwood S. K., Xie Y., Wang X., Signal transduction pathways leading to heat shock transcription. Sign Transduct Insights 2010 2 13 24
21. Ellis R. J., Protein misassembly: macromolecular crowding and molecular chaperones. Advances in Experimental Medicine and Biology 2007 594 1 13 2-s2.0-33846924074 10.1007/978-0-387-39975-1-1
22. Mayer M. P., Bukau B., Hsp70 chaperones: cellular functions and molecular mechanism. Cellular and Molecular Life Sciences 2005 62 6 670 684 2-s2.0-17044387386 10.1007/s00018-004-4464-6
23. Craig E. A., The stress response: changes in eukaryotic gene expression in response to environmental stress. Science 1985 230 800 801
24. van Eden W., Heat-shock proteins as immunogenic bacterial antigens with the potential to induce and regulate autoimmune arthritis. Immunological Reviews 1991 121 5 28 2-s2.0-0025921494
25. Van Eden W., Wick G., Albani S., Cohen I., Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Annals of the New York Academy of Sciences 2007 1113 217 237 2-s2.0-35548988445 10.1196/annals.1391.020 (Pubitemid 350015017)
26. Quintana F. J., Carmi P., Mor F., Cohen I. R., Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Arthritis and Rheumatism 2004 50 11 3712 3720 2-s2.0-8444238954 10.1002/art.20635 (Pubitemid 39488701)
27. Borges T. J., Wieten L., van Herwijnen M. J., The anti-inflammatory mechanisms of Hsp70. Frontiers in Immunology 2012 3 95
28. Calderwood S. K., Khaleque M. A., Sawyer D. B., Ciocca D. R., Heat shock proteins in cancer: chaperones of tumorigenesis. Trends in Biochemical Sciences 2006 31 3 164 172 2-s2.0-33644835965 10.1016/j.tibs.2006.01.006 (Pubitemid 43361923)
29. Ciocca D. R., Calderwood S. K., Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress and Chaperones 2005 10 2 86 103 2-s2.0-21744445069 10.1379/CSC-99r.1 (Pubitemid 40942470)
30. Trepel J., Mollapour M., Giaccone G., Neckers L., Targeting the dynamic HSP90 complex in cancer. Nature Reviews Cancer 2010 10 8 537 549 2-s2.0-77954945333 10.1038/nrc2887
31. Calderwood S. K., Gong J., Molecular chaperones in mammary cancer growth and breast tumor therapy. ournal of Cellular Biochemistry 2011 113 4 1096 1103
32. Srivastava P., Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annual Review of Immunology 2002 20 395 425 2-s2.0-0036214288 10.1146/annurev.immunol.20.100301.064801 (Pubitemid 34293430)
33. Pockley A. G., Heat shock proteins, inflammation, and cardiovascular disease. Circulation 2002 105 8 1012 1017 2-s2.0-0037176975 10.1161/hc0802. 103729 (Pubitemid 34184583)
34. Mambula S. S., Calderwood S. K., Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. Journal of Immunology 2006 177 11 7849 7857 2-s2.0-33750570923 (Pubitemid 44848243)
35. Mambula S. S., Calderwood S. K., Heat induced release of Hsp70 from prostate carcinoma cells involves both active secretion and passive release from necrotic cells. International Journal of Hyperthermia 2006 22 7 575 585 2-s2.0-33750567138 10.1080/02656730600976042 (Pubitemid 44669663)
36. Chalmin F., Ladoire S., Mignot G., Vincent J., Bruchard M., Remy-Martin J. P., Boireau W., Rouleau A., Simon B., Lanneau D., De Thonel A., Multhoff G., Hamman A., Martin F., Chauffert B., Solary E., Zitvogel L., Garrido C., Ryffel B., Borg C., Apetoh L., Rébé C., Ghiringhelli F., Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. Journal of Clinical Investigation 2010 120 2 457 471 2-s2.0-76649097628 10.1172/JCI40483
37. Stocki P., Wang X. N., Dickinson A. M., Inducible heat shock protein 70 reduces T cell responses and stimulatory capacity of monocyte-derived dendritic cells. The Journal of Biological Chemistry 2012 287 12387 12394
38. Banerjee S., Lin C. F. L., Skinner K. A., Schiffhauer L. M., Peacock J., Hicks D. G., Redmond E. M., Morrow D., Huston A., Shayne M., Langstein H. N., Miller-Graziano C. L., Strickland J., O'Donoghue L., De A. K., Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression. Cancer Research 2011 71 2 318 327 2-s2.0-78751562690 10.1158/0008-5472.CAN-10-1778
39. Miller-Graziano C. L., De A., Laudanski K., Herrmann T., Bandyopadhyay S., HSP27: an anti-inflammatory and immunomodulatory stress protein acting to dampen immune function. Novartis Foundation Symposium 2008 291 196 208 2-s2.0-52449127527
40. Vabulas R. M., Ahmad-Nejad P., da Costa C., Miethke T., Kirschning C. J., Häcker H., Wagner H., Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. Journal of Biological Chemistry 2001 276 33 31332 31339 2-s2.0-0035903158 10.1074/jbc.M103217200 (Pubitemid 37385004)
41. + T cells respond to self heat shock protein 60 (HSP60). PLoS ONE 2011 6 e24119
42. + T cells with a regulatory phenotype. Journal of Immunology 2010 185 4 2071 2079 2-s2.0-77956908756 10.4049/jimmunol.0901901
43. Ma J. H., Sui Y. F., Ye J., Huang Y. Y., Li Z. S., Chen G. S., Qu P., Song H. P., Zhang X. M., Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo. Cancer Immunology, Immunotherapy 2005 54 9 907 914 2-s2.0-22244454703 10.1007/s00262-004-0660-3 (Pubitemid 40991333)
44. Murata S., Minami Y., Minami M., Chiba T., Tanaka K., CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Reports 2001 2 12 1133 1138 2-s2.0-0035684430 10.1093/embo-reports/kve246 (Pubitemid 34055961)
45. Cohen-Sfady M., Pevsner-Fischer M., Margalit R., Cohen I. R., Heat shock protein 60, via MyD88 innate signaling, protects B cells from apoptosis, spontaneous and induced. Journal of Immunology 2009 183 2 890 896 2-s2.0-70249150440 10.4049/jimmunol.0804238
46. Cohen-Sfady M., Nussbaum G., Pevsner-Fischer M., Mor F., Carmi P., Zanin-Zhorov A., Lider O., Cohen I. R., Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. Journal of Immunology 2005 175 6 3594 3602 2-s2.0-24744442576 (Pubitemid 41292018)
47. Štrbo N., Yamazaki K., Lee K., Rukavina D., Podack E. R., Heat shock fusion protein gp96-Ig mediates strong CD8 CTL expansion in vivo. American Journal of Reproductive Immunology 2002 48 4 220 225 2-s2.0-0036785091 10.1034/j.1600-0897.2002.01118.x
48. Yamazaki K., Nguyen T., Podack E. R., Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. Journal of Immunology 1999 163 10 5178 5182 2-s2.0-0033571087
49. Beachy S. H., Kisailus A. J., Repasky E. A., Subjeck J. R., Wang X. Y., Kazim A. L., Engineering secretable forms of chaperones for immune modulation and vaccine development. Methods 2007 43 3 184 193 2-s2.0-34848899804 10.1016/j.ymeth.2007.06.001 (Pubitemid 47499073)
50. Gao P., Sun X., Chen X., Subjeck J., Wang X. Y., Secretion of stress protein grp170 promotes immune-mediated inhibition of murine prostate tumor. Cancer Immunology, Immunotherapy 2009 58 8 1319 1328 2-s2.0-67349207888 10.1007/s00262-008-0647-6
51. Murshid A., Gong J., Stevenson M. A., KCalderwood S., Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come. Expert Review of Vaccines 2011 10 1553 1568
52. Udono H., Srivastava P. K., Heat shock protein 70-associated peptides elicit specific cancer immunity. Journal of Experimental Medicine 1993 178 4 1391 1396 2-s2.0-0027260585 (Pubitemid 23277370)
53. Melcher A., Todryk S., Hardwick N., Ford M., Jacobson M., Vile R. G., Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nature Medicine 1998 4 5 581 587 2-s2.0-0031836938 10.1038/nm0598-581 (Pubitemid 28237357)
54. Wang X. Y., Kazim L., Repasky E. A., Subjeck J. R., Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. Journal of Immunology 2001 166 1 490 497 2-s2.0-0035167866 (Pubitemid 32038468)
55. Noessner E., Gastpar R., Milani V., Brandl A., Hutzler P. J. S., Kuppner M. C., Roos M., Kremmer E., Asea A., Calderwood S. K., Issels R. D., Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. Journal of Immunology 2002 169 10 5424 5432 2-s2.0-0037111218 (Pubitemid 35291639)
56. Manjili M. H., Wang X. Y., Chen X., Martin T., Repasky E. A., Henderson R., Subjeck J. R., HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice. Journal of Immunology 2003 171 8 4054 4061 2-s2.0-0141992909 (Pubitemid 37238680)
57. Mazzaferro V., Coppa J., Carrabba M. G., Rivoltini L., Schiavo M., Regalia E., Mariani L., Camerini T., Marchianò A., Andreola S., Camerini R., Corsi M., Lewis J. J., Srivastava P. K., Parmiani G., Vaccination with autologous tumor-derived heat-shock protein Gp96 after liver resection for metastatic colorectal cancer. Clinical Cancer Research 2003 9 9 3235 3245 2-s2.0-10744233222 (Pubitemid 37082717)
58. Mayer M. P., Brehmer D., Gässler C. S., Bukau B., Hsp70 chaperone machines. Advances in Protein Chemistry 2001 59 1 44 2-s2.0-0035716744 10.1016/S0065-3233(01)59001-4 (Pubitemid 34169300)
59. Murshid A., Gong J., Calderwood S. K., Purification, preparation and use of a chaperone-peptide complexes for tumor immunotherapy. Methods in Molecular Biology. In press
60. Chandawarkar R. Y., Wagh M. S., Srivastava P. K., The dual nature of specific immunological activity of tumor-derived gp96 preparations. Journal of Experimental Medicine 1999 189 9 1437 1442 2-s2.0-0345299172 10.1084/jem.189.9.1437 (Pubitemid 29227529)
61. Van Eden W., Van Der Zee R., Prakken B., Heat-shock proteins induce T-cell regulation of chronic inflammation. Nature Reviews Immunology 2005 5 4 318 330 2-s2.0-17144417382 10.1038/nri1593 (Pubitemid 40516157)
62. Delneste Y., Magistrelli G., Gauchat J. F., Haeuw J. F., Aubry J. P., Nakamura K., Kawakami-Honda N., Goetsch L., Sawamura T., Bonnefoy J. Y., Jeannin P., Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 2002 17 3 353 362 2-s2.0-18644364531 10.1016/S1074-7613(02)00388-6 (Pubitemid 35279555)
63. Singh-Jasuja H., Toes R. E. M., Spee P., Münz C., Hilf N., Schoenberger S. P., Ricciardi-Castagnoli P., Neefjes J., Rammensee H. G., Arnold-Schild D., Schild H., Cross-presentation of glycoprotein 96-associated antigens: on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. Journal of Experimental Medicine 2000 191 11 1965 1974 2-s2.0-0034608387 10.1084/jem.191.11.1965 (Pubitemid 30390358)
64. Murshid A., Gong J., Calderwood S. K., Heat shock protein 90 mediates efficient antigen cross presentation through the scavenger receptor expressed by endothelial cells-I. Journal of Immunology 2010 185 5 2903 2917 2-s2.0-78049397567 10.4049/jimmunol.0903635
65. Nicchitta C. V., Carrick D. M., Baker-LePain J. C., The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity. Cell Stress and Chaperones 2004 9 4 325 331 2-s2.0-12744269479 10.1379/CSC-62.1
66. Jockheck-Clark A. R., Bowers E. V., Totonchy M. B., Neubauer J., Pizzo S. V., Nicchitta C. V., Re-examination of CD91 function in GRP94 (glycoprotein 96) surface binding, uptake, and peptide cross-presentation. Journal of Immunology 2010 185 11 6819 6830 2-s2.0-78650667874 10.4049/jimmunol.1000448
67. Thériault J. R., Adachi H., Calderwood S. K., Role of scavenger receptors in the binding and internalization of heat shock protein 70. Journal of Immunology 2006 177 12 8604 8611 2-s2.0-33845446813 (Pubitemid 44893823)
68. Binder R. J., Han D. K., Srivastava P. K., CD91: a receptor for heat shock protein gp96. Nature Immunology 2000 1 2 151 155 2-s2.0-0034252620
69. Murshid A., Gong J., Calderwood S. K., The role of heat shock proteins in antigen cross presentation. Frontiers in Immunology 2012 3, article 63
70. Thériault J. R., Mambula S. S., Sawamura T., Stevenson M. A., Calderwood S. K., Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells. FEBS Letters 2005 579 9 1951 1960 2-s2.0-15544373100 10.1016/j.febslet.2005.02.046 (Pubitemid 40404037)
71. Gong J., Zhu B., Murshid A., Adachi H., Song B., Lee A., Liu C., Calderwood S. K., T cell activation by heat shock protein 70 vaccine requires TLR signaling and scavenger receptor expressed by endothelial cells-1. Journal of Immunology 2009 183 5 3092 3098 2-s2.0-70349235599 10.4049/jimmunol.0901235
72. Imai T., Kato Y., Kajiwara C., Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for crosspresentation by dendritic cells. The Proceedings of the National Academy of Sciences of the United States of America 2011 108 16363 16368
73. Oura J., Tamura Y., Kamiguchi K., Kutomi G., Sahara H., Torigoe T., Himi T., Sato N., Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells. International Immunology 2011 23 4 223 237 2-s2.0-79953326945 10.1093/intimm/dxq475
74. + T cells by antigen donor cells is GRP94 independent. Journal of Immunology 2009 183 7 4205 4210 2-s2.0-70449719355 10.4049/jimmunol.0901828
75. Kurts C., Robinson B. W. S., Knolle P. A., Cross-priming in health and disease. Nature Reviews Immunology 2010 10 6 403 414 2-s2.0-77952838480 10.1038/nri2780
76. Bennett S. R. M., Carbone F. R., Karamalis F., Flavell R. A., Miller J. F. A. P., Heath W. R., Help for cytotoxic-T-cell responses is mediated by CD4O signalling. Nature 1998 393 6684 478 480 2-s2.0-0032482356
77. Croft M., Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nature Reviews Immunology 2003 3 8 609 620 2-s2.0-0141609073 (Pubitemid 37328664)
78. Matzinger P., The danger model: a renewed sense of self. Science 2002 296 5566 301 305 2-s2.0-0037066427 10.1126/science.1071059 (Pubitemid 34303674)
79. Hayden M. S., Ghosh S., Signaling to NF- κ B. Genes and Development 2004 18 18 2195 2224 2-s2.0-4444376712 10.1101/gad.1228704 (Pubitemid 39209568)
80. Tesniere A., Apetoh L., Ghiringhelli F., Joza N., Panaretakis T., Kepp O., Schlemmer F., Zitvogel L., Kroemer G., Immunogenic cancer cell death: a key-lock paradigm. Current Opinion in Immunology 2008 20 5 504 511 2-s2.0-50549102898 10.1016/j.coi.2008.05.007
81. Rock K. L., Hearn A., Chen C. J., Shi Y., Natural endogenous adjuvants. Springer Seminars in Immunopathology 2005 26 3 231 246 2-s2.0-12444252115 10.1007/s00281-004-0173-3
82. Calderwood S. K., Murshid A., Gong J., Heat shock proteins: conditional mediators of inflammation in tumor immunity. Frontiers in Immunology 2012 3, article 75
83. Takeda K., Kaisho T., Akira S., Toll-like receptors. Annual Review of Immunology 2003 21 335 376 2-s2.0-0012929728 10.1146/annurev.immunol.21.120601. 141126 (Pubitemid 37174535)
84. Asea A., Kraeft S. K., Kurt-Jones E. A., Stevenson M. A., Chen L. B., Finberg R. W., Koo G. C., Calderwood S. K., HSP70 stimulates cytokine production through a CD 14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nature Medicine 2000 6 4 435 442 2-s2.0-0034113617 10.1038/74697 (Pubitemid 30208161)
85. Gao B., Tsan M. F., Induction of cytokines by heat shock proteins and endotoxin in murine macrophages. Biochemical and Biophysical Research Communications 2004 317 4 1149 1154 2-s2.0-1942516288 10.1016/j.bbrc.2004.03.160 (Pubitemid 38496430)
86. Calderwood S. K., Gong J., Murshid A., Heat shock proteins: conditional mediators of inflammation in tumor immunity. Frontiers in Inflammation 2012 3, article 75 10.3389/fimmu.2012.00075
87. Enomoto Y., Bharti A., Khaleque A. A., Song B., Liu C., Apostolopoulos V., Xing P. X., Calderwood S. K., Gong J., Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells. Journal of Immunology 2006 177 9 5946 5955 2-s2.0-33750359212 (Pubitemid 44628808)
88. Multhoff G., Hightower L. E., Distinguishing integral and receptor-bound heat shock protein 70 (Hsp70) on the cell surface by Hsp70-specific antibodies. Cell Stress and Chaperones 2011 16 3 251 255 2-s2.0-79958752336 10.1007/s12192-010-0247-1
89. Gross C., Koelch W., DeMaio A., Arispe N., Multhoff G., Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B. Journal of Biological Chemistry 2003 278 42 41173 41181 2-s2.0-0142103373 10.1074/jbc.M302644200 (Pubitemid 37280943)
90. Wang L., Rollins L., Gu Q., Chen S. Y., Huang X. F., A Mage3/Heat Shock Protein70 DNA vaccine induces both innate and adaptive immune responses for the antitumor activity. Vaccine 2009 28 2 561 570 2-s2.0-70649111280 10.1016/j.vaccine.2009.09.119
91. Gong J., Zhang Y., Durfee J., Weng D., Liu C., Koido S., Song B., Apostolopoulos V., Calderwood S. K., A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use. Journal of Immunology 2010 184 1 488 496 2-s2.0-73949095492 10.4049/jimmunol.0902255
92. Weng D., Calderwood S. K., Gong J., Preparation of a heat shock proteinbased vaccine from dendritic cells. Methods in Molecular Biology 2011 787 255 65
93. Daniels G. A., Sanchez-Perez L., Diaz R. M., Kottke T., Thompson J., Lai M., Gough M., Karim M., Bushell A., Chong H., Melcher A., Harrington K., Vile R. G., A simple method to cure established tumors by inflammatory killing of normal cells. Nature Biotechnology 2004 22 9 1125 1132 2-s2.0-4444345447 10.1038/nbt1007 (Pubitemid 39166850)
94. Kottke T., Sanchez-Perez L., Diaz R. M., Thompson J., Chong H., Harrington K., Calderwood S. K., Pulido J., Georgopoulos N., Selby P., Melcher A., Vile R., Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer Research 2007 67 24 11970 11979 2-s2.0-37549008775 10.1158/0008-5472.CAN-07-2259
95. Afzali B., Lombardi G., Lechler R. I., Lord G. M., The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clinical and Experimental Immunology 2007 148 1 32 46 2-s2.0-33847667225 10.1111/j.1365-2249.2007.03356.x (Pubitemid 46365005)
96. Spaeth E. L., Dembinski J. L., Sasser A. K., Watson K., Klopp A., Hall B., Andreeff M., Marini F., Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE 2009 4 4 2-s2.0-64549145804 10.1371/journal.pone.0004992 e4992
97. Schatton T., Schütte U., Frank N. Y., Zhan Q., Hoerning A., Robles S. C., Zhou J., Hodi F. S., Spagnoli G. C., Murphy G. F., Frank M. H., Modulation of T-cell activation by malignant melanoma initiating cells. Cancer Research 2010 70 2 697 708 2-s2.0-76549126237 10.1158/0008-5472.CAN-09-1592
98. Srivastava P. K., Therapeutic cancer vaccines. Current Opinion in Immunology 2006 18 201 205 (Pubitemid 43327303)
99. Shi Y., Evans J. E., Rock K. L., Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003 425 6957 516 521 2-s2.0-0141998606 10.1038/nature01991 (Pubitemid 37237047)
100. Chen Q., Fisher D. T., Clancy K. A., Gauguet J. M. M., Wang W. C., Unger E., Rose-John S., von Andrian U. H., Baumann H., Evans S. S., Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nature Immunology 2006 7 12 1299 1308 2-s2.0-33846325078 10.1038/ni1406 (Pubitemid 46111251)
101. Demaria S., Bhardwaj N., McBride W. H., Formenti S. C., Combining radiotherapy and immunotherapy: a revived partnership. International Journal of Radiation Oncology Biology Physics 2005 63 3 655 666 2-s2.0-25844459044 10.1016/j.ijrobp.2005.06.032 (Pubitemid 41400049)
102. Zerbini A., Pilli M., Fagnoni F., Pelosi G., Pizzi M. G., Schivazappa S., Laccabue D., Cavallo C., Schianchi C., Ferrari C., Missale G., Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation. Journal of Immunotherapy 2008 31 3 271 282 2-s2.0-41149120115 10.1097/CJI.0b013e318160ff1c (Pubitemid 351440997)
103. Dulos J., Carven G. J., van Boxtel S. J., PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer. Journal of Immunotherapy 2012 35 169 178
104. Tarhini A. A., Kirkwood J. M., CTLA-4-blocking immunotherapy with ipilimumab for advanced melanoma. Oncology 2010 24 14 1302 1304 2-s2.0-79952272922
105. Chen L., Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nature Reviews Immunology 2004 4 5 336 347 2-s2.0-2442585121 (Pubitemid 38649276)
106. Sah A., Bhattacharya-Chatterjee M., Foon K. A., Celis E., Chatterjee S. K., Stimulatory effects of CpG ollgodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice. International Journal of Cancer 2009 124 4 877 888 2-s2.0-58149477220 10.1002/ijc.24009